UNH

UnitedHealth Group Inc

Add to Watchlist

Advanced Chart

380.640

-4.910(-1.270%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

386.5525

Open

385.670

VWAP

381.27

Vol

8.38M

Mkt Cap

345.29B

Low

378.540

Amount

3.20B

EV/EBITDA(TTM)

10.53

Total Shares

920.39M

405.98B

EV/OCF(TTM)

14.24

P/S(TTM)

0.86

UnitedHealth Group Incorporated is a healthcare company. The Company has two businesses, Optum and UnitedHealthcare. Optum serves the health care marketplace, including patients and consumers, payers, care providers, employers, governments and life sciences companies. UnitedHealthcare offers a full range of health benefits designed to simplify the health care experience and make it more affordable for consumers to access care. UnitedHealthcare Employer & Individual serves consumers and employers, ranging from sole proprietorships to large, multi-site and national employers and public sector employers. UnitedHealthcare Medicare & Retirement delivers health and well-being benefits to seniors and other Medicare eligible consumers. The Company’s segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. UnitedHealthcare segment includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

115.17B

+14.25%

6.144

-9.78%

114.09B

+13.16%

6.661

-6.84%

111.99B

+13.29%

6.194

-8.91%

Estimates Revision

The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.32% over the past three months. During the same period, the stock price has changed by -28.71%.

Revenue Estimates for FY2025

Revise Downward

-0.32%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-12%

In Past 3 Month

Stock Price

Go Down

-28.71%

In Past 3 Month

25 Analyst Rating

48.43% Upside

Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 565.00 USD with a low forecast of 490.00 USD and a high forecast of 700.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

22 Buy

3 Hold

0 Sell

Strong Buy

48.43% Upside

Current: 380.640

Low

490.00

Averages

565.00

High

700.00

48.43% Upside

Current: 380.640

Low

490.00

Averages

565.00

High

700.00

Baird

Michael Ha

Buy

Maintains

$640 → $510

2025-04-29

Reason

Baird

Michael Ha

Price Target

$640 → $510

2025-04-29

Maintains

Buy

Reason

Baird analyst Michael Ha lowered the firm's price target on UnitedHealth to $510 from $640 and keeps an Outperform rating on the shares. The firm updated its model and said it remains their number one pick.

JP Morgan

Lisa Gill

Buy

Maintains

$652 → $525

2025-04-24

Reason

JP Morgan

Lisa Gill

Price Target

$652 → $525

2025-04-24

Maintains

Buy

Reason

Barclays

Andrew Mok

Buy

Maintains

$560 → $513

2025-04-24

Reason

Barclays

Andrew Mok

Price Target

$560 → $513

2025-04-24

Maintains

Buy

Reason

Barclays lowered the firm's price target on UnitedHealth to $560 from $642 and keeps an Overweight rating on the shares following the Q1 report.

RBC Capital

Ben Hendrix

Buy

Maintains

$655 → $525

2025-04-23

Reason

RBC Capital

Ben Hendrix

Price Target

$655 → $525

2025-04-23

Maintains

Buy

Reason

RBC Capital lowered the firm's price target on UnitedHealth to $525 from $655 but keeps an Outperform rating on the shares. The firm is updating its model following the company's Q1 earnings miss earlier this month, though the management's early recognition of lower engagement of new Optum Health members leading to lower-than-expected reimbursement levels as well as higher-than-expected Medicare Advantage utilization should inform accurate 2026 pricing, giving RBC confidence that these headwinds are addressable in the intermediate term, the analyst tells investors in a research note.

Morgan Stanley

Ricky Goldwasser

Buy

Maintains

$664 → $563

2025-04-22

Reason

Morgan Stanley

Ricky Goldwasser

Price Target

$664 → $563

2025-04-22

Maintains

Buy

Reason

Morgan Stanley analyst Erin Wright raised the firm's price target on UnitedHealth to $664 from $610 and keeps an Overweight rating on the shares. While policy will be "front and center" with varying degrees of exposure, or lack there of, across the Healthcare Services and Technology space, the focus will also be on indications of underlying utilization trends across MCOs, distributors, providers, labs, animal and dental into Q1, the analyst tells investors in a preview for the group.

HSBC

Sidharth Sahoo

Strong Buy

Hold

Downgrades

n/a

2025-04-22

Reason

HSBC

Sidharth Sahoo

Price Target

n/a

2025-04-22

Downgrades

Strong Buy

Hold

Reason

HSBC downgraded UnitedHealth to Hold from Buy with a $490 price target.

See All Ratings

Valuation Metrics

The current forward P/E ratio for UnitedHealth Group Inc (UNH.N) is 14.05, compared to its 5-year average forward P/E of 19.97. For a more detailed relative valuation and DCF analysis to assess UnitedHealth Group Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Strongly Undervalued

5Y Average PE

19.97

Current PE

14.05

Overvalued PE

21.97

Undervalued PE

17.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Strongly Undervalued

5Y Average EV/EBITDA

14.16

Current EV/EBITDA

10.41

Overvalued EV/EBITDA

15.51

Undervalued EV/EBITDA

12.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Undervalued

5Y Average PS

1.24

Current PS

0.75

Overvalued PS

1.39

Undervalued PS

1.10

Financials

Annual

Quarterly

FY2025Q1

YoY :

+9.80%

109.58B

Total Revenue

FY2025Q1

YoY :

+6.98%

9.12B

Operating Profit

FY2025Q1

YoY :

-630.22%

6.47B

Net Income after Tax

FY2025Q1

YoY :

-547.71%

6.85

EPS - Diluted

FY2025Q1

YoY :

+1036.66%

4.56B

Free Cash Flow

FY2025Q1

YoY :

+119.13%

6.07

FCF Margin - %

FY2025Q1

YoY :

-584.43%

5.91

Net Margin - %

FY2025Q1

YoY :

-196.90%

591.83

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

439.0K

USD

0-12

Months

2.5M

USD

Bought

0-3

0.0

USD

Months

3-6

511.6K

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

3.4M

Volume

6-9

Months

0.0

Volume

0-12

Months

4.5M

Volume

Bought

0-3

0.0

Volume

Months

3-6

3.4M

Volume

Months

6-9

0.0

Volume

Months

0-12

115

14.0M

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

73.0K

USD

3-6

Months

261.5K

USD

6-9

Months

115.5K

USD

0-12

Months

0.0

USD

Bought

0-3

138.0K

USD

Months

3-6

97.5K

USD

Months

6-9

8.0K

USD

Months

0-12

8.0K

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

439.0K

USD

0-12

Months

2.5M

USD

Bought

0-3

0.0

USD

Months

3-6

511.6K

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

UNH News & Events

Events Timeline

2025-05-07 (ET)

2025-05-07

15:52:59

UnitedHealth investors sue over concealing backlash from killing, Reuters says

2025-05-05 (ET)

2025-05-05

11:51:41

Providers upset by UnitedHealth's move to end cyberattack loan, NYT reports

2025-04-30 (ET)

2025-04-30

06:20:46

Drugmakers spend millions targeting 'middlemen,' WSJ reports

News

3.0

05-10CNBC

These stocks, including Microsoft, just entered overbought territory and may be due for a pullback

8.0

05-09NASDAQ.COM

Noteworthy Friday Option Activity: WOLF, UNH, TTEC

4.5

05-09MarketWatch

Salesforce, IBM share losses contribute to Dow's 100-point drop

People Also Watch

INVZ

Innoviz Technologies Ltd

Alpha Tau Medical Ltd

Cooper-Standard Holdings Inc

Ambipar Emergency Response

Aclaris Therapeutics Inc

FAQ

What is UnitedHealth Group Inc (UNH) stock price today?

The current price of UNH is 380.64 USD — it has decreased -1.27 % in the last trading day.

UNH

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

UNH News & Events

Events Timeline

News

People Also Watch

FAQ

What is UnitedHealth Group Inc (UNH) stock price today?

What is UnitedHealth Group Inc (UNH)'s business?

What is the price predicton of UNH Stock?

What is UnitedHealth Group Inc (UNH)'s revenue for the last quarter?

What is UnitedHealth Group Inc (UNH)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for UnitedHealth Group Inc (UNH)'s fundamentals?

How many employees does UnitedHealth Group Inc (UNH). have?

What is UnitedHealth Group Inc (UNH) market cap?